Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The American Thyroid Association Multidisciplinary Consensus Statement on Ambulatory Thyroid Surgery.

Thyroid : official journal of the American Thyroid Association·2026

Same author

A missed opportunity to discuss treatment costs? A qualitative analysis of preoperative conversations about thyroid cancer treatment.

Surgery·2026

Same author

Thermogenic Gene Expression in Human Neck Adipose Tissue in Relation to Circulating and Local Thyroid Hormone Levels.

Journal of the Endocrine Society·2025

Same author

Assessing the success of the American Association of Endocrine Surgeons research awards.

Surgery·2025

Same author

Localized Re-Entry Involving the Coronary Sinus: The Latest Model of Manufactured Arrhythmias.

JACC. Clinical electrophysiology·2025

Same author

Resident Individual Clinical Evaluations: Resident Perspectives And Effectiveness.

Journal of surgical education·2025

Same journal

Genotype-phenotype associations of <i>MKRN</i>3 variants in children with central precocious puberty: a single-center study from Uzbekistan.

Journal of pediatric endocrinology & metabolism : JPEM·2026

Same journal

Birth prevalence and characterisation of congenital hyperinsulinism in Western Australia over two decades.

Journal of pediatric endocrinology & metabolism : JPEM·2026

Same journal

Erratum to: Reliability of point-of-care glucose in neonates: revisiting hypoglycemia protocols in the NICU.

Journal of pediatric endocrinology & metabolism : JPEM·2026

Same journal

Evaluation of the relationship between HOMA-IR, triglyceride-glucose index, and triglyceride/HDL-cholesterol ratio with the presence and severity of hepatic steatosis in children with obesity.

Journal of pediatric endocrinology & metabolism : JPEM·2026

Same journal

Reflections on GnRH analogues dosage in the context of escape phenomenon: a case report of hypothalamic hamartoma with central precocious puberty and literature review.

Journal of pediatric endocrinology & metabolism : JPEM·2026

Same journal

Steroid profiling in congenital adrenal hyperplasia: comparing immunoassays and LC-MS/MS accuracy.

Journal of pediatric endocrinology & metabolism : JPEM·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 27, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Pediatric toxic polycystic thyroid.

Janeil M Belle¹, Nektarios Vasilottos¹, Todd D Nebesio¹

¹.

Journal of Pediatric Endocrinology & Metabolism : JPEM

|July 5, 2017

Summary

This summary is machine-generated.

Polycystic thyroid disease (PCTD) is a rare condition. This report details the first pediatric case of PCTD with hyperthyroidism, highlighting its occurrence in children.

Keywords:

pediatric hyperthyroidism pediatric thyroid disease polycystic thyroid cyst

More Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Feb 27, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Area of Science:

Endocrinology
Pediatric Endocrinology
Thyroidology

Background:

Polycystic thyroid disease (PCTD) is a rare endocrine disorder typically observed in adults with hypothyroidism.
This study presents the first documented case of diffuse macrocystic degeneration of the thyroid in a pediatric patient.

Observation:

A 6-year-old presented with a 16-month history of an enlarging polycystic thyroid and hyperthyroidism.
Autoimmune thyroid disease markers were negative, and there was no family history of thyroid or cystic disease.
The patient underwent total thyroidectomy and is now euthyroid with hormone replacement therapy.

Findings:

This case represents the first reported instance of PCTD in a pediatric patient associated with hyperthyroidism.
The hyperthyroidism was not linked to autoimmune thyroid disease, suggesting alternative underlying mechanisms.
The patient's condition resolved post-thyroidectomy, with ongoing management for euthyroidism.

Implications:

Polycystic thyroid degeneration can manifest in children, potentially leading to hyperthyroidism.
Further research is needed to explore the potential role of somatic activating thyrotropin-receptor gene mutations in pediatric PCTD.
This case expands the known clinical spectrum of PCTD and its presentation in pediatric populations.